The Kano State Government has reaffirmed its commitment to expanding access to quality medicines, improving digital supply chain systems, and strengthening transparency and accountability across the healthcare sector.
The State Commissioner for Health, Dr. Abubakar Labaran, made this known while chairing the 10th Quarterly Review Meeting of the Kano State Drugs and Medical Consumables Supply Agency (DMCSA).
Kano DMCSA Clears ₦980m Debt, Boosts Drug Availability to 97%
Dr. Labaran noted that ongoing reforms have positioned the agency as a model for supply chain excellence in the region, marking a significant milestone in efforts to ensure uninterrupted access to life-saving drugs and medical consumables.
He highlighted key achievements recorded during the review period, attributing the progress to strategic reforms, prudent financial management, and sustained commitment to effective service delivery.
Also speaking, Dr. Yusuf assured residents that the agency remains focused on consolidating its successes and strengthening the state’s healthcare supply chain system.
Kano DMCSA Opens Bids for 2026 Drug, Medical Supply Contracts
The commissioner commended the Kano State Government under the leadership of Governor Abba Kabir Yusuf for its continued support to the Ministry of Health, as well as development partners for their contributions to improving healthcare delivery in the state.
In his welcome address, the Director General of DMCSA, Pharm. Gali Sule, disclosed that the agency recorded a significant funding increase of ₦628,774,541, boosting its operational capacity and enhancing procurement and distribution processes.
He added that drug availability across health facilities rose to 93.8 percent, reflecting improved inventory management and efficient distribution systems.
“This milestone ensures consistent availability of essential medicines to meet the healthcare needs of our growing population,” he said.
Pharm. Sule further revealed that the agency cleared inherited liabilities totaling ₦1.178 billion, demonstrating strong fiscal discipline and accountability while laying a solid foundation for sustainable growth.
He reaffirmed the agency’s commitment to sustaining these gains through continuous innovation and collaboration with stakeholders.
During the meeting, presentations were made reviewing operational activities of DMCSA and other health-related agencies and programmes.
At the end of the session, an Award of Leadership in Supply Chain was presented to the Commissioner for Health, while Pharm. Tukur Ibrahim, immediate past Director of Drugs and Supply at DMCSA, received an Award of Excellence in recognition of his contributions to pharmaceutical services.